The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis

The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis

Low skeletal muscle mass (LSMM) is increasingly recognized for its predictive value for adverse events in cancer patients. In specific, the predictive value of LSMM has been demonstrated for anti-cancer drug toxicity in a variety of cancer types and anti-cancer drugs. However, due to the limited sam...

Full description

Bibliographic Details
Main Authors: Laura F. J. Huiskamp, Najiba Chargi, Lot A. Devriese, Anne M. May, Alwin D. R. Huitema, Remco de Bree
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
low skeletal muscle mass
cancer
meta-analysis
toxicity
anti-cancer drugs
Online Access:https://www.mdpi.com/2077-0383/9/11/3780

Similar Items

Similar Items